Literature DB >> 16115015

Protective effect of melatonin on rotenone plus Ca2+-induced mitochondrial oxidative stress and PC12 cell death.

Solange C Sousa1, Roger F Castilho.   

Abstract

Chronic systemic inhibition of mitochondrial respiratory chain complex I by rotenone causes nigrostriatal dopaminergic degeneration in rats, producing an in vivo experimental model of Parkinson's disease. We recently showed that micromolar Ca2+ concentrations strongly stimulate the release of reactive oxygen species in rotenone-treated isolated rat brain mitochondria. In the present work, we show that the natural antioxidant melatonin inhibits Ca2+ plus rotenone-induced oxidative stress in isolated rat brain mitochondria. In addition, the Ca2+ ionophore A23187 strongly potentiates rotenone-induced death of intact cultured pheochromocytoma (PC12) cells, in a mechanism sensitive to melatonin. Moreover, melatonin inhibits the detection of reactive oxygen species release in PC12 cells treated with rotenone plus A23187. Melatonin does not alter free Ca2+ concentrations or the inhibitory effect of rotenone on mitochondrial complex I. We conclude that micromolar Ca2+ concentrations stimulate neuronal cell death induced by mitochondrial complex I inhibition in a mechanism involving oxidative stress, preventable by the antioxidant melatonin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115015     DOI: 10.1089/ars.2005.7.1110

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

Review 1.  Melatonin, mitochondria, and the cancer cell.

Authors:  Sara Proietti; Alessandra Cucina; Mirko Minini; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 2.  Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?

Authors:  Naveen Kumar Singhal; Garima Srivastava; Sonal Agrawal; Swatantra Kumar Jain; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2011-12-24       Impact factor: 5.590

3.  Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells.

Authors:  Corinne E Griguer; Claudia R Oliva; G Yancey Gillespie; Eric Gobin; Pascale Marcorelles; G Yancey Gillespie
Journal:  J Neurooncol       Date:  2006-07-22       Impact factor: 4.130

4.  Effects of partial inhibition of respiratory complex I on H2O 2 production by isolated brain mitochondria in different respiratory states.

Authors:  Luiz G B Michelini; Carlos E Benevento; Franco A Rossato; Edilene S Siqueira-Santos; Roger F Castilho
Journal:  Neurochem Res       Date:  2014-10-07       Impact factor: 3.996

5.  PGC-1ɑ Mediated-EXOG, a Specific Repair Enzyme for Mitochondrial DNA, Plays an Essential Role in the Rotenone-Induced Neurotoxicity of PC12 Cells.

Authors:  Jingsong Xiao; Xunhu Dong; Kaige Peng; Feng Ye; Jin Cheng; Guorong Dan; Zhongmin Zou; Jia Cao; Yan Sai
Journal:  J Mol Neurosci       Date:  2021-01-30       Impact factor: 3.444

6.  Melatonin combats molecular terrorism at the mitochondrial level.

Authors:  Russel J Reiter; Sergio D Paredes; Ahmet Korkmaz; Mei-Jie Jou; Dun-Xian Tan
Journal:  Interdiscip Toxicol       Date:  2008-09

Review 7.  Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases.

Authors:  Carlos Fernández-Moriano; Elena González-Burgos; M Pilar Gómez-Serranillos
Journal:  Oxid Med Cell Longev       Date:  2015-04-29       Impact factor: 6.543

Review 8.  Age-Associated Glia Remodeling and Mitochondrial Dysfunction in Neurodegeneration: Antioxidant Supplementation as a Possible Intervention.

Authors:  Anna Picca; Evelyn Ferri; Riccardo Calvani; Hélio J Coelho-Júnior; Emanuele Marzetti; Beatrice Arosio
Journal:  Nutrients       Date:  2022-06-09       Impact factor: 6.706

Review 9.  Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration.

Authors:  Nicola Pacini; Fabio Borziani
Journal:  Int J Mol Sci       Date:  2016-03-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.